Support
Support
Search

Cardiac Diagnostics for Value-Based Care

A doctor and a patient having a conversation

Enabling better patient outcomes and more cost-effective care.

Active cardiac monitoring with the Zio service is associated with these outcomes*:

iRhythm data circles
iRhythm data circles

*Compared to usual care
**Assumes 10,000 members, 2,500 eligible with 25% participation.

CAMELOT: NEW REAL-WORLD EVIDENCE

Compared with all other monitoring services, Zio LTCM service was associated with the highest diagnostic yield and lowest retest likelihood.4-7
Learn Why
Woman wearing a Zio monitor

Transforming the way cardiac arrhythmias are diagnosed

As a market leader in cardiology diagnostics and arrhythmia detection, iRhythm has served more than 6.5 million patients and analyzed 1.5 billion hours of heartbeat data through our Zio service.8,9

 

We’re on a mission to address the future of healthcare, partnering with risk-based organizations to detect and prevent cardiovascular disease - all while helping you save money and save lives.

Improve patient access and quality outcomes.

1

Close specialty care gaps and keep appropriate patients in primary care.

2

Find arrhythmias earlier in the patient care journey to expedite time to treatment.

3

Earlier diagnosis and treatment can reduce unnecessary ED visits and preventable cardiac events.

Who We Serve

Value-based primary care

Accountable Care Organizations (ACOs)

Clinically Integrated Networks (CINs)

Health assessment organizations

Healthcare enablers

Payers/Payviders

Improve Key Performance Measures

HEDIS Measures +
Cardiovascular Health

By integrating proactive surveillance for heart arrhythmias into routine care, you have the opportunity to drive better patient outcomes and impact key HEDIS measures related to cardiovascular health.

Find untapped value-based care opportunities. Contact us today.

  1. Waalen, et al., Healthcare resource utilization following ECG sensor patch screening for atrial fibrillation. Heart Rhythm O2, 2020.
  2. Steinhubl, et al., Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening mHealth Screening to Prevent Strokes (mSToPS). PLOS ONE, 2021.
  3. Directional and potential outcome based upon modeling using iRhythm's mSToPS Calculator. iRhythm Technologies, 2023.

  4. Reynolds et al. Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries. Am Heart J. 2024;269:25–34. Accessed January 2, 2024. 
    https://doi.org/10.1016/j.ahj.2023.12.002

  5. In testing for specified arrhythmias defined by Hierarchical Condition Categories (HCC) 96.
  6. Based on previous generation Zio XT device data. Zio monitor utilizes the same operating principles and ECG algorithm. Additional data on file.
  7. Zio LTCM service refers to Zio XT and Zio monitor service.
  8. Data on file. iRhythm Technologies. 2022.
  9. Form 10-K 2022. iRhythm Technologies, 2022. Retrieved from https://s201.q4cdn.com/653785554/files/doc_financials/2022/ar/Annual-Report.pdf
Contact Us

WEB0015.01